Condition (MeSH)
Port-Wine Stain
ClinicalTrials.gov lists 45 trials for Port-Wine Stain or a narrower condition beneath it. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. has the most among industry and government lead sponsors, with 4.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
45 of the 45 trials are tagged with Port-Wine Stain itself; the rest are tagged with a narrower condition beneath it.
When did Port-Wine Stain trials start? (22)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 1/2
- Phase 2
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 4
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 2 |
| 2025 | 1 |
| 2024 | 3 |
| 2023 | 2 |
| 2022 | 1 |
| 2020 | 4 |
| 2019 | 1 |
| 2017 | 2 |
| 2016 | 1 |
| 2015 | 1 |
Showing 10 of 22 earlier years.
No forecast is made for this condition: it averages 1.8 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 3 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Port-Wine Stain trials in? (7)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 7 |
| Phase 1/2 | 1 |
| Phase 2 | 4 |
| Phase 3 | 1 |
| Phase 4 | 4 |
| Not applicable | 19 |
| Observational | 9 |
How many Port-Wine Stain trials are recruiting? (7)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 1 |
| Recruiting | 5 |
| Completed | 22 |
| Suspended | 1 |
| Terminated | 4 |
Showing 5 of 7 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Port-Wine Stain trials? (2)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | 4 |
| Candela Corporation | 1 |
Which drugs are being tested for Port-Wine Stain? (5)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| EVEROLIMUS | 1 |
| Hematoporphyrin | 1 |
| Talaporfin Sodium | 1 |
| Sirolimus | 1 |
| BOSENTAN | 1 |
Interventions as named in the registry (9)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Hemoporfin PDT | 2 |
| Laser and rapamycin versus laser alone | 1 |
| Rapamycin Treatment of Port Wine Stain | 1 |
| Topical Antiangiogenic | 1 |
| Haemoblock | 1 |
Showing 5 of 9 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which publications cover Port-Wine Stain? (36)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
Showing 5 of 36 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.